Inc. (NASDAQ:OM), a medical technology company focused on innovating dialysis treatment, has resolved all concerns raised in a Warning Letter from the U.S. Food and Drug Administration (FDA) dating ...
DelveInsight's Artificial Kidney Market Insights report provides the current and forecast market analysis, individual leading ...
Outset Medical (OM) announced it has been notified by the FDA that all issues cited in a warning letter the company received in July of 2023 ...
Ianalumab, for the treatment of primary immune thrombocytopenia, was granted FDA orphan designation, according to a post on the ...
The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$27.72 billion in 2024 and an impressive US$56.94 billion ...
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...
Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results